| __timestamp | Viking Therapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22223073 | 396000000 |
| Thursday, January 1, 2015 | 6966842 | 364000000 |
| Friday, January 1, 2016 | 9000499 | 376000000 |
| Sunday, January 1, 2017 | 13741186 | 382000000 |
| Monday, January 1, 2018 | 19040000 | 432000000 |
| Tuesday, January 1, 2019 | 23559000 | 457000000 |
| Wednesday, January 1, 2020 | 31931000 | 463000000 |
| Friday, January 1, 2021 | 44981000 | 508000000 |
| Saturday, January 1, 2022 | 54234000 | 539000000 |
| Sunday, January 1, 2023 | 63806000 | 614000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, research and development (R&D) budgets are pivotal. Over the past decade, Zoetis Inc. and Viking Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. Zoetis, a leader in animal health, consistently allocated substantial resources, with a peak of $614 million in 2023, marking a 55% increase from 2014. In contrast, Viking Therapeutics, a smaller player in the biotech sector, showed a remarkable growth trajectory, with R&D expenses surging by nearly 187% from 2014 to 2023, reaching $64 million. This divergence highlights Zoetis's steady commitment to innovation, while Viking's aggressive scaling reflects its ambition to carve a niche in the competitive biotech market. As the industry continues to innovate, these R&D investments will likely shape the future of healthcare solutions.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Sanofi vs Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Viking Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. or Viking Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Viking Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.